STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

KPTIEUR Schedule 13G/A filing by BlackRock

BlackRock reported beneficial ownership of 10.1M shares, representing 8.8% of KARYOPHARM THERAPEUTICS INC in this filing.

FiledJan 25, 2024
Ownership dateDec 31, 2023
Reported shares10.1M
Reported ownership8.8%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 10.1M
Shared voting power 10.1M
Sole dispositive power 10.1M
Shared dispositive power 10.1M
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
BlackRock
CIK
CIK0001364742
Accession
0001086364-24-003344
Form
Schedule 13G/A
Open SEC filing View KPTIEUR ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →